N6 ‐Methyladenosine‐Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR ‐1236‐3p/ GPX2 Axis
Cancer Science · 2025-12 · 116 (12) · 3326-3336
DOI: 10.1111/cas.70203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 24.09.2025. Verfasst von Qian Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Department of Hepatology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, P. R. C…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Circular, MicroRNAs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
circRNAs are endogenous covalently closed circular RNAs, and previous studies have validated their key regulatory roles in malignant tumors; however, the specific role and regulatory mechanism of circNEK11 in hepatocellular carcinoma (HCC) remain unclear. Here, we discovered that circNEK11 back‐spliced from exons 12, 13, 14, and 15 of the NEK11 gene is significantly upregulated in HCC tissues, especially recurrent HCC tissues. YTHDC1 functions as a reader of m6A‐modified circNEK11 and facilitates its cytoplasmic export. circNEK11 promotes HCC cell oncogenic functions in vitro and HCC growth in vivo. Mechanistically, circNEK11 directly binds to miR‐1236‐3p to regulate GPX2 expression, thus promoting HCC progression and recurrence. Collectively, our findings suggest that circNEK11 is a potential biomarker and target for HCC diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Department of Hepatology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, P. R. China.
- Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, Zhejiang, P. R. China.
- Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Hangzhou Normal University, Hangzhou, Zhejiang, P. R. China.
- Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang, P. R. China.
- Department of Gastroenterology, Affiliated Nanjing Jiangbei Hospital of Xinglin College, Nantong University, Nanjing, P. R. China.
ORCID-Profile: Qian Li, Jianxiang Chen
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Li, Q., Huang, X., Tong, Y., Yong, C., Song, M., Chang, C., Dong, H., Bu, F., Yan, S., Ying, J., & Chen, J. (2025). N6 ‐Methyladenosine‐Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR ‐1236‐3p/ GPX2 Axis. Cancer Science, 116(12), 3326-3336. https://doi.org/10.1111/cas.70203
Vancouver
Li Q, Huang X, Tong Y, Yong C, Song M, Chang C, et al. N6 ‐Methyladenosine‐Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR ‐1236‐3p/ GPX2 Axis. Cancer Science. 2025;116(12):3326-3336. doi:10.1111/cas.70203
BibTeX
@article{Li2025,
author = {Li, Qian and Huang, Xu and Tong, Yan and Yong, Caiyu and Song, Minghui and Chang, Cunjie and Dong, Heng and Bu, Fangtian and Yan, Shuanghong and Ying, Jie and Chen, Jianxiang},
title = {N6 ‐Methyladenosine‐Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR ‐1236‐3p/ GPX2 Axis},
journal = {Cancer Science},
year = {2025},
volume = {116},
number = {12},
pages = {3326--3336},
doi = {10.1111/cas.70203}
}
EUVIMED